	Transforming Growth Factor-Beta 1 as a Predictive Biomarker for Radiation-Induced Lung Toxicity and Treatment Response in Lung Cancer: A Systematic Review and Meta-analysis. Adv Radiat Oncol Feng LC, Lin CM, Tseng YC. PMID: 42100442 [PubMed]
	Glioblastoma recurrence followed by newly diagnosed small cell lung cancer: a case report on personalized concurrent chemoradiotherapy and therapeutic considerations. Front Oncol Ren X, Shang F, Yang D, Yan Y, Xu Y. PMID: 42100415 [PubMed]
	Non-small cell lung cancer after EGFR-TKI resistance: from drug resistance mechanisms to precision interventions. Front Pharmacol Wang Z, Song Y, Wang A, Liu B. PMID: 42100320 [PubMed]
	Prognostic value of preoperative inflammatory markers in resectable non-small cell lung cancer: a multi-center retrospective study based on logistic regression and machine learning techniques. Front Med (Lausanne) Cai X, Lin D, Wang S, Li J, Zhou X, Liu H. PMID: 42100267 [PubMed]
	Progress in the application of 68Ga-Pentixafor PET/CT in lung cancer: a review. Oncol Rev Liu L, Zhang J. PMID: 42099745 [PubMed]
	The early changed rate of sTg to TSH ratio had superior predictive value in evaluating long-term prognosis for pulmonary metastatistic differentiated thyroid carcinoma. Future Oncol Li J, Zhang Y, Wang C, Lu C, Han N, Wang G, Jia Q, Tan J, Wang X, Meng Z. PMID: 42099276 [PubMed - as supplied by publisher]
	Prospective study assessing the feasibility of hippocampal-sparing radiotherapy in lung cancer patients requiring cranial irradiation. Strahlenther Onkol Khosla D, Dey T, Trivedi G, Kapoor R, Singh N, Kataria V, Singla AK, Madan R, Goyal S, Oinam AS, Mehta A, Sharma A, Periasamy K. PMID: 42098481 [PubMed - as supplied by publisher]
	Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence. Eur Radiol Antonissen N, Schalekamp S, Hahn HK, van Leeuwen KG, Jacobs C. PMID: 42098370 [PubMed - as supplied by publisher]
	Distinct roles of WHO Score, CCI, and CFS in prognosis and treatment decisions for non-small cell lung cancer: A retrospective real-world study. Cancer Treat Res Commun Paappanen V, Jukkola A, Klaavuniemi T, Sailas L, Ahvonen J, Kuitunen H, Selander T, Tengström M, Kärkkäinen M, Kuittinen O, Tiainen S. PMID: 42096838 [PubMed - as supplied by publisher]
	Phase II study of ramucirumab plus erlotinib for treatment-naÃ¯ve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion). Lung Cancer Kaneda H, Tachihara M, Toi Y, Kuyama S, Ichihara E, Fujisaka Y, Azuma K, Kurata T, Kubo A, Tanaka H, Yamada T, Yokoyama T, Kato T, Yamamoto K, Katakami N, Kawai R, Yoshida H, Shintani A, Sawa K, Kawaguchi T. PMID: 42096800 [PubMed - as supplied by publisher]
	[Sinonasal ameloblastoma: Clinical case presentation and literature review]. Rev Med Inst Mex Seguro Soc Martínez-Fernández FJ, Juárez-Aguilar FG. PMID: 42096278 [PubMed - indexed for MEDLINE]
	[Early preeclampsia associated with hydatidiform mole and pulmonary metastasis: A case report]. Rev Med Inst Mex Seguro Soc Rivera-Hernández DA, Montes-Sevilla LD, Murcia-Acero DX, Castillo Medina AL. PMID: 42096254 [PubMed - indexed for MEDLINE]
	LUMINATE-101-Maccabi: a real-world study of treatment patterns and clinical outcomes in patients with non-squamous metastatic non-small cell lung cancer in an Israeli health maintenance organization (HMO). Expert Rev Anticancer Ther Moser SS, Zer A, Hejazi A, Passwell N, Hoshen M, Virani A, Sharmokh S, Daaboul N, Gazit S, Bar J. PMID: 42096187 [PubMed - as supplied by publisher]
	Genetic influence of PPAR-Î³ rs1801282 and MTRR rs162036 variants on non-small cell lung cancer risk in Egyptians. Discov Oncol Metwally YF, Zahran RF, El Sadda RR, Refaat S, Elsaid AM. PMID: 42096170 [PubMed]
	Imaging and AI in tertiary prevention of lung cancer: Narrative review and clinical perspectives. Multidiscip Respir Med Molfini Curci C, Morabito A, Pagliaro R, Perrotta F, Ottaiano A, Santone A, D'Agnano V, Mormile R, Gallipoli D'Errico A, Bianco A, Picone C. PMID: 42095808 [PubMed]
	GLUT1 rs1385129G>A Raised the Risk and Poor Prognosis of Lung Cancer: A Case-Control Study. Hum Mutat Li Z, Wang D, Chen J, Wu D, Tang S, Huang J, Deng Y, Wang X, Qiu F, Yang L, Lu J. PMID: 42094236 [PubMed - indexed for MEDLINE]
	Epigenetic inflammation signatures and lung cancer risk among never-smoking women: a nested case-control study. medRxiv Rahman ML, Gargapati A, Hurwitz LM, Hu W, Keil AP, Breeze CE, Chaturvedi A, Shi J, Cai Q, Yang G, Long J, Gao YT, Christiani DC, Rothman N, Zheng W, Shu XO, Wong JYY, Lan Q. PMID: 42094136 [PubMed]
	Orchestration of the tumor microenvironment by citrus flavonoids: from preclinical mechanisms to translational therapeutic. Front Immunol Ma S, Wang X, Li M, Wang W, Ren Y, Shen Y, Yang K, Zhang Z, Feng Z, Tang S. PMID: 42094009 [PubMed - indexed for MEDLINE]
	Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms. Front Immunol He L, Sun Y, Ma B, Lang G, Wen J, Blumenschein GR Jr, Ma H. PMID: 42093990 [PubMed - indexed for MEDLINE]
	Modeling metastasis and predicting drug response with malignant effusion-derived organoids: a systematic review and quantitative assessment. J Transl Med Peng J, Tian S, Liu L, Deng Y. PMID: 42092978 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 158472

Page 1 of 7924



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy